|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 1Q22 (Arabic)
|
08 Apr 2022
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 4Q21 (Arabic)
|
10 Jan 2021
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 3Q21 (Arabic)
|
05 Oct 2021
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 2Q21 (Arabic)
|
12 Jul 2021
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 1Q21 (Arabic)
|
08 Apr 2021
|
|
Disclosure to EGX Outlining Changes to the Company's Organizational Framework (Form 208)
|
05 Apr 2021
|
|
Disclosure to EGX Outlining Changes to the Company's Data (Form 210)
|
05 Apr 2021
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 4Q20 (Arabic)
|
11 Jan 2021
|
|
Disclosure to EGX regarding the completion of the restructuring process and merger of RG Investment
|
18 Oct 2020
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 3Q20 (Arabic)
|
06 Oct 2020
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 2Q20 (Arabic)
|
09 Sep 2020
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 1Q20 (Arabic)
|
16 Apr 2020
|
|
Disclosure to EGX Outlining Changes to the Company's Data (Form 210)
|
05 Apr 2020
|
|
Disclosure to EGX Outlining Changes to the Company's Organizational Framework (Form 208)
|
05 Apr 2020
|
|
Disclosure regarding the final transfer of Dr. Raouf Ghabbour's shares
|
02 May 2019
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 2Q19 (Arabic)
|
01 Apr 2019
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 1Q19 (Arabic)
|
01 Feb 2019
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 4Q18 (Arabic)
|
01 Dec 2018
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 3Q18 (Arabic)
|
01 Sep 2018
|
|
Disclosure Regarding the Sale of Stake in MNT Investment B.V.
|
13 Aug 2018
|
|
Disclosure regarding the sale of a c.20% stake in MNT Investment B.V
|
08 Aug 2018
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 2Q18 (Arabic)
|
01 Jun 2018
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 1Q18 (Arabic)
|
01 Feb 2018
|
|
Disclosure to EGX Outlining BOD and Shareholder Structures as of 4Q17 (Arabic)
|
04 Mar 2018
|
|
Disclosure to EGX outlining BOD and shareholder structures as of 3Q17 (Arabic)
|
01 Sep 2017
|
|
Disclosure to EGX outlining BOD and shareholder structures as of 2Q17 (Arabic)
|
01 Jun 2017
|
|
Disclosure regarding the transfer of Dr. Raouf Ghabbour's shares
|
01 May 2017
|
|
Disclosure to EGX outlining BOD and shareholder structures as of 1Q17 (Arabic)
|
01 Feb 2017
|
